Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy
Clinical trial NCT07289763 · RECRUITING
Trial details
- NCT number
- NCT07289763
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-31
- Primary completion
- 2027-08-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.